Management of Phyllodes Breast Tumors

:  Phyllodes tumors are a rare distinctive fibroepithelial tumors of the breast and their management continues to be questioned. The aim of our study was to examine the treatment and outcome of 165 patients with phyllodes tumors and to review the options for surgical management. This is a retrospect...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The breast journal 2011-03, Vol.17 (2), p.129-137
Hauptverfasser: Guillot, Eugenie, Couturaud, Benoit, Reyal, Fabien, Curnier, Alain, Ravinet, Julie, Laé, Marick, Bollet, Marc, Pierga, Jean-yves, Salmon, Remy, Fitoussi, Alfred
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 137
container_issue 2
container_start_page 129
container_title The breast journal
container_volume 17
creator Guillot, Eugenie
Couturaud, Benoit
Reyal, Fabien
Curnier, Alain
Ravinet, Julie
Laé, Marick
Bollet, Marc
Pierga, Jean-yves
Salmon, Remy
Fitoussi, Alfred
description :  Phyllodes tumors are a rare distinctive fibroepithelial tumors of the breast and their management continues to be questioned. The aim of our study was to examine the treatment and outcome of 165 patients with phyllodes tumors and to review the options for surgical management. This is a retrospective study of 165 patients who presented to the Institut Curie between January 1994 and November 2008 for benign, borderline or malignant phyllodes tumors. The median follow‐up was 12.65 months [range 0–149.8]. The median age at diagnosis was 44 years [range 17–79]. One hundred and sixty patients (97%) had breast‐conserving treatment, of whom 3 patients (1.8%) had oncoplastic breast surgery. Younger women had a significantly higher chance of having a benign phyllodes tumor (p = 0.0001) or a tumor of small size (p 
doi_str_mv 10.1111/j.1524-4741.2010.01045.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_857813850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>857813850</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4065-33ad3e69b720ad33a2796e483edc4673e12df8b89beb4f329d8fd0fb1b9109943</originalsourceid><addsrcrecordid>eNqNkE9Pg0AQxTdGY2v1KxguxhO4f2E5eNCq1aZqYzD1tllgUCqUykJsv72LrT27yWRfZt6bSX4IOQR7xL6LuUcE5S4POPEotl1bXHirPdTfDfatxoFwCaVvPXRkzBxjTEPMD1GPEiqIrT46e9QL_Q4lLBqnypzpx7ooqhSMc12DNo0TtWVVm2N0kOnCwMn2H6DXu9toeO9OnkcPw6uJm3DsC5cxnTLwwzig2CqmaRD6wCWDNOF-wIDQNJOxDGOIecZomMosxVlM4pDgMORsgM43e5d19dWCaVSZmwSKQi-gao2SIpCESYGtU26cSV0ZU0OmlnVe6nqtCFYdIzVXHQrVoVAdI_XLSK1s9HR7pI1LSHfBPyjWcLkxfOcFrP-9WEXX407ZvLvJ56aB1S6v609lIQRCzZ5GajYdBi_8Zqwi9gObBYJp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>857813850</pqid></control><display><type>article</type><title>Management of Phyllodes Breast Tumors</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Guillot, Eugenie ; Couturaud, Benoit ; Reyal, Fabien ; Curnier, Alain ; Ravinet, Julie ; Laé, Marick ; Bollet, Marc ; Pierga, Jean-yves ; Salmon, Remy ; Fitoussi, Alfred</creator><creatorcontrib>Guillot, Eugenie ; Couturaud, Benoit ; Reyal, Fabien ; Curnier, Alain ; Ravinet, Julie ; Laé, Marick ; Bollet, Marc ; Pierga, Jean-yves ; Salmon, Remy ; Fitoussi, Alfred ; Breast Cancer Study Group of the Institut Curie ; Breast Cancer Study Group of the Institut Curie</creatorcontrib><description>:  Phyllodes tumors are a rare distinctive fibroepithelial tumors of the breast and their management continues to be questioned. The aim of our study was to examine the treatment and outcome of 165 patients with phyllodes tumors and to review the options for surgical management. This is a retrospective study of 165 patients who presented to the Institut Curie between January 1994 and November 2008 for benign, borderline or malignant phyllodes tumors. The median follow‐up was 12.65 months [range 0–149.8]. The median age at diagnosis was 44 years [range 17–79]. One hundred and sixty patients (97%) had breast‐conserving treatment, of whom 3 patients (1.8%) had oncoplastic breast surgery. Younger women had a significantly higher chance of having a benign phyllodes tumor (p = 0.0001) or a tumor of small size (p &lt; 0.0001). Histologic examination showed 114 benign (69%), 37 borderline (22%) and 14 malignant tumors (9%). The median tumor size was 30 mm [range 5–150]. The tumor margins were considered incomplete (&lt;10 mm) in 46 out of 165 cases (28%) with 52% revision surgery. Only the tumor grade was a significant risk factor for incomplete tumor margins (p = 0.005). Fifteen patients developed local recurrence (10%) and two, metastases. In univariate analysis, the histologic grade (p = 0.008), and tumor size (p = 0.02) were significative risk factors for local recurrence with an accentuated risk for “borderline” tumors and tumors of large size.).Similar results were obtained using multivariate analysis (p = 0.07). The mainstay of treatment for phyllodes tumors remains excision with a safe surgical margin, taking advantage breast conserving surgery where amenable. For borderline or malignant phyllodes tumors or in cases of local tumor recurrence, mastectomy, and immediate breast reconstruction may become the preferred option. Genetic analysis will potentially supplement classical histologic examination in order to improve our management of these tumors. The role of adjuvant treatments is unproven and must be considered on a case‐by‐case basis.</description><identifier>ISSN: 1075-122X</identifier><identifier>EISSN: 1524-4741</identifier><identifier>DOI: 10.1111/j.1524-4741.2010.01045.x</identifier><identifier>PMID: 21251125</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Aged ; breast cancer ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Chemotherapy, Adjuvant ; Female ; Follow-Up Studies ; Humans ; Incidence ; Mastectomy ; Mastectomy, Segmental ; Middle Aged ; Neoplasm Recurrence, Local - epidemiology ; oncoplastic surgery ; phyllode ; Phyllodes Tumor - pathology ; Phyllodes Tumor - secondary ; Phyllodes Tumor - surgery ; Radiotherapy, Adjuvant ; Reoperation - statistics &amp; numerical data ; Retrospective Studies ; Risk Factors ; Young Adult</subject><ispartof>The breast journal, 2011-03, Vol.17 (2), p.129-137</ispartof><rights>2011 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4065-33ad3e69b720ad33a2796e483edc4673e12df8b89beb4f329d8fd0fb1b9109943</citedby><cites>FETCH-LOGICAL-c4065-33ad3e69b720ad33a2796e483edc4673e12df8b89beb4f329d8fd0fb1b9109943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1524-4741.2010.01045.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1524-4741.2010.01045.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21251125$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guillot, Eugenie</creatorcontrib><creatorcontrib>Couturaud, Benoit</creatorcontrib><creatorcontrib>Reyal, Fabien</creatorcontrib><creatorcontrib>Curnier, Alain</creatorcontrib><creatorcontrib>Ravinet, Julie</creatorcontrib><creatorcontrib>Laé, Marick</creatorcontrib><creatorcontrib>Bollet, Marc</creatorcontrib><creatorcontrib>Pierga, Jean-yves</creatorcontrib><creatorcontrib>Salmon, Remy</creatorcontrib><creatorcontrib>Fitoussi, Alfred</creatorcontrib><creatorcontrib>Breast Cancer Study Group of the Institut Curie</creatorcontrib><creatorcontrib>Breast Cancer Study Group of the Institut Curie</creatorcontrib><title>Management of Phyllodes Breast Tumors</title><title>The breast journal</title><addtitle>Breast J</addtitle><description>:  Phyllodes tumors are a rare distinctive fibroepithelial tumors of the breast and their management continues to be questioned. The aim of our study was to examine the treatment and outcome of 165 patients with phyllodes tumors and to review the options for surgical management. This is a retrospective study of 165 patients who presented to the Institut Curie between January 1994 and November 2008 for benign, borderline or malignant phyllodes tumors. The median follow‐up was 12.65 months [range 0–149.8]. The median age at diagnosis was 44 years [range 17–79]. One hundred and sixty patients (97%) had breast‐conserving treatment, of whom 3 patients (1.8%) had oncoplastic breast surgery. Younger women had a significantly higher chance of having a benign phyllodes tumor (p = 0.0001) or a tumor of small size (p &lt; 0.0001). Histologic examination showed 114 benign (69%), 37 borderline (22%) and 14 malignant tumors (9%). The median tumor size was 30 mm [range 5–150]. The tumor margins were considered incomplete (&lt;10 mm) in 46 out of 165 cases (28%) with 52% revision surgery. Only the tumor grade was a significant risk factor for incomplete tumor margins (p = 0.005). Fifteen patients developed local recurrence (10%) and two, metastases. In univariate analysis, the histologic grade (p = 0.008), and tumor size (p = 0.02) were significative risk factors for local recurrence with an accentuated risk for “borderline” tumors and tumors of large size.).Similar results were obtained using multivariate analysis (p = 0.07). The mainstay of treatment for phyllodes tumors remains excision with a safe surgical margin, taking advantage breast conserving surgery where amenable. For borderline or malignant phyllodes tumors or in cases of local tumor recurrence, mastectomy, and immediate breast reconstruction may become the preferred option. Genetic analysis will potentially supplement classical histologic examination in order to improve our management of these tumors. The role of adjuvant treatments is unproven and must be considered on a case‐by‐case basis.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>breast cancer</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Chemotherapy, Adjuvant</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Incidence</subject><subject>Mastectomy</subject><subject>Mastectomy, Segmental</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>oncoplastic surgery</subject><subject>phyllode</subject><subject>Phyllodes Tumor - pathology</subject><subject>Phyllodes Tumor - secondary</subject><subject>Phyllodes Tumor - surgery</subject><subject>Radiotherapy, Adjuvant</subject><subject>Reoperation - statistics &amp; numerical data</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Young Adult</subject><issn>1075-122X</issn><issn>1524-4741</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE9Pg0AQxTdGY2v1KxguxhO4f2E5eNCq1aZqYzD1tllgUCqUykJsv72LrT27yWRfZt6bSX4IOQR7xL6LuUcE5S4POPEotl1bXHirPdTfDfatxoFwCaVvPXRkzBxjTEPMD1GPEiqIrT46e9QL_Q4lLBqnypzpx7ooqhSMc12DNo0TtWVVm2N0kOnCwMn2H6DXu9toeO9OnkcPw6uJm3DsC5cxnTLwwzig2CqmaRD6wCWDNOF-wIDQNJOxDGOIecZomMosxVlM4pDgMORsgM43e5d19dWCaVSZmwSKQi-gao2SIpCESYGtU26cSV0ZU0OmlnVe6nqtCFYdIzVXHQrVoVAdI_XLSK1s9HR7pI1LSHfBPyjWcLkxfOcFrP-9WEXX407ZvLvJ56aB1S6v609lIQRCzZ5GajYdBi_8Zqwi9gObBYJp</recordid><startdate>201103</startdate><enddate>201103</enddate><creator>Guillot, Eugenie</creator><creator>Couturaud, Benoit</creator><creator>Reyal, Fabien</creator><creator>Curnier, Alain</creator><creator>Ravinet, Julie</creator><creator>Laé, Marick</creator><creator>Bollet, Marc</creator><creator>Pierga, Jean-yves</creator><creator>Salmon, Remy</creator><creator>Fitoussi, Alfred</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201103</creationdate><title>Management of Phyllodes Breast Tumors</title><author>Guillot, Eugenie ; Couturaud, Benoit ; Reyal, Fabien ; Curnier, Alain ; Ravinet, Julie ; Laé, Marick ; Bollet, Marc ; Pierga, Jean-yves ; Salmon, Remy ; Fitoussi, Alfred</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4065-33ad3e69b720ad33a2796e483edc4673e12df8b89beb4f329d8fd0fb1b9109943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>breast cancer</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Chemotherapy, Adjuvant</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Incidence</topic><topic>Mastectomy</topic><topic>Mastectomy, Segmental</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>oncoplastic surgery</topic><topic>phyllode</topic><topic>Phyllodes Tumor - pathology</topic><topic>Phyllodes Tumor - secondary</topic><topic>Phyllodes Tumor - surgery</topic><topic>Radiotherapy, Adjuvant</topic><topic>Reoperation - statistics &amp; numerical data</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guillot, Eugenie</creatorcontrib><creatorcontrib>Couturaud, Benoit</creatorcontrib><creatorcontrib>Reyal, Fabien</creatorcontrib><creatorcontrib>Curnier, Alain</creatorcontrib><creatorcontrib>Ravinet, Julie</creatorcontrib><creatorcontrib>Laé, Marick</creatorcontrib><creatorcontrib>Bollet, Marc</creatorcontrib><creatorcontrib>Pierga, Jean-yves</creatorcontrib><creatorcontrib>Salmon, Remy</creatorcontrib><creatorcontrib>Fitoussi, Alfred</creatorcontrib><creatorcontrib>Breast Cancer Study Group of the Institut Curie</creatorcontrib><creatorcontrib>Breast Cancer Study Group of the Institut Curie</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The breast journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guillot, Eugenie</au><au>Couturaud, Benoit</au><au>Reyal, Fabien</au><au>Curnier, Alain</au><au>Ravinet, Julie</au><au>Laé, Marick</au><au>Bollet, Marc</au><au>Pierga, Jean-yves</au><au>Salmon, Remy</au><au>Fitoussi, Alfred</au><aucorp>Breast Cancer Study Group of the Institut Curie</aucorp><aucorp>Breast Cancer Study Group of the Institut Curie</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of Phyllodes Breast Tumors</atitle><jtitle>The breast journal</jtitle><addtitle>Breast J</addtitle><date>2011-03</date><risdate>2011</risdate><volume>17</volume><issue>2</issue><spage>129</spage><epage>137</epage><pages>129-137</pages><issn>1075-122X</issn><eissn>1524-4741</eissn><abstract>:  Phyllodes tumors are a rare distinctive fibroepithelial tumors of the breast and their management continues to be questioned. The aim of our study was to examine the treatment and outcome of 165 patients with phyllodes tumors and to review the options for surgical management. This is a retrospective study of 165 patients who presented to the Institut Curie between January 1994 and November 2008 for benign, borderline or malignant phyllodes tumors. The median follow‐up was 12.65 months [range 0–149.8]. The median age at diagnosis was 44 years [range 17–79]. One hundred and sixty patients (97%) had breast‐conserving treatment, of whom 3 patients (1.8%) had oncoplastic breast surgery. Younger women had a significantly higher chance of having a benign phyllodes tumor (p = 0.0001) or a tumor of small size (p &lt; 0.0001). Histologic examination showed 114 benign (69%), 37 borderline (22%) and 14 malignant tumors (9%). The median tumor size was 30 mm [range 5–150]. The tumor margins were considered incomplete (&lt;10 mm) in 46 out of 165 cases (28%) with 52% revision surgery. Only the tumor grade was a significant risk factor for incomplete tumor margins (p = 0.005). Fifteen patients developed local recurrence (10%) and two, metastases. In univariate analysis, the histologic grade (p = 0.008), and tumor size (p = 0.02) were significative risk factors for local recurrence with an accentuated risk for “borderline” tumors and tumors of large size.).Similar results were obtained using multivariate analysis (p = 0.07). The mainstay of treatment for phyllodes tumors remains excision with a safe surgical margin, taking advantage breast conserving surgery where amenable. For borderline or malignant phyllodes tumors or in cases of local tumor recurrence, mastectomy, and immediate breast reconstruction may become the preferred option. Genetic analysis will potentially supplement classical histologic examination in order to improve our management of these tumors. The role of adjuvant treatments is unproven and must be considered on a case‐by‐case basis.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21251125</pmid><doi>10.1111/j.1524-4741.2010.01045.x</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1075-122X
ispartof The breast journal, 2011-03, Vol.17 (2), p.129-137
issn 1075-122X
1524-4741
language eng
recordid cdi_proquest_miscellaneous_857813850
source MEDLINE; Access via Wiley Online Library
subjects Adolescent
Adult
Aged
breast cancer
Breast Neoplasms - pathology
Breast Neoplasms - surgery
Chemotherapy, Adjuvant
Female
Follow-Up Studies
Humans
Incidence
Mastectomy
Mastectomy, Segmental
Middle Aged
Neoplasm Recurrence, Local - epidemiology
oncoplastic surgery
phyllode
Phyllodes Tumor - pathology
Phyllodes Tumor - secondary
Phyllodes Tumor - surgery
Radiotherapy, Adjuvant
Reoperation - statistics & numerical data
Retrospective Studies
Risk Factors
Young Adult
title Management of Phyllodes Breast Tumors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T12%3A42%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20Phyllodes%20Breast%20Tumors&rft.jtitle=The%20breast%20journal&rft.au=Guillot,%20Eugenie&rft.aucorp=Breast%20Cancer%20Study%20Group%20of%20the%20Institut%20Curie&rft.date=2011-03&rft.volume=17&rft.issue=2&rft.spage=129&rft.epage=137&rft.pages=129-137&rft.issn=1075-122X&rft.eissn=1524-4741&rft_id=info:doi/10.1111/j.1524-4741.2010.01045.x&rft_dat=%3Cproquest_cross%3E857813850%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=857813850&rft_id=info:pmid/21251125&rfr_iscdi=true